What Researchers Did
Researchers investigated the effectiveness of hyperbaric oxygenation in 69 patients with vibration disease, using varying pressure regimens over 10 sessions.
What They Found
They found that hyperbaric oxygen treatment at 1.3 atm was justified for patients with preclinical signs of vibration disease. For patients with clinical manifestations of grade I-II severity, increasing the hyperbaric oxygen dose to 1.5 atm was deemed appropriate.
What This Means for Canadian Patients
This study suggests that hyperbaric oxygenation could be a potential treatment option for Canadian patients suffering from vibration disease, an occupational health concern. Depending on the disease severity, different pressure levels of hyperbaric oxygen may be beneficial.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in 1990 and published in a non-Canadian journal.
Study Limitations
The abstract does not detail specific study limitations, but potential limitations include the small sample size and the lack of a control group.